POCN Hem/Onc
Reduced-Dose Onivyde is Effective for Treatment of Advanced Pancreatic Cancer
| Categories: pcn, pocn-hem-onc
In a real-world study, dose reductions (DRs) of liposomal irinotecan (Onivyde) were effective and associated with improved clinical outcomes in the treatment of pancreatic cancer. Liposomal […]